## QLYS: Qualys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 2.6% below STRENGTH zone (3.0-6.0%); PEG 4.10 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($143.69)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 15 ($3.95M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 15.3% (-2.6%)
- Vanguard Group Inc: 12.3% (+2.9%)
- State Street Corpora: 3.9% (-1.6%)
- Geode Capital Manage: 3.4% (+0.3%)
- Boston Trust Walden : 3.2% (+0.7%)

### Key Risks

1. Insider selling cluster: $3.9M in recent transactions.
2. Valuation stretched: PEG 4.1x requires aggressive growth execution.
3. Elevated short interest (12.4%): bears positioning against stock.

### Catalysts

- Momentum building: MRS_10 improving +2.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.10 signals overvaluation risk, limited margin of safety. Forward P/E 20.6x stretched relative to 6% growth. Quality metrics strong (ROE 39%, ROA 14%, margin 29%). Insider selling cluster ($3.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.5B |
| Beta | 0.55 |
| 52W Range | $112.61 - $155.47 |
| Short Interest | 12.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.10 |
| Forward P/E | 20.6 |
| Current P/E | 21.8 |
| YoY Growth | 5.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -0.3% to 2.6% (+2.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.4pp (needs >3.0% for momentum thesis). MRS_5 at 1.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.53), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.60% (CS: 66) | Neutral |
| RSI_14 | 65.3 | Neutral |
| MACD Histogram | 0.53 | Bullish |
| vs SMA20 | 1.055x | Above |
| vs SMA50 | 1.113x | Above |
| vs SMA200 | 1.136x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $152.31
- **Stop Loss:** $143.69 (5.7% risk)
- **Target:** $160.93 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 160
- **Position Value:** $24,369.60
- **Portfolio %:** 24.37%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $1.78)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.56 | $1.86 | +19.2% |
| 2025Q2 | $1.48 | $1.68 | +13.3% |
| 2025Q1 | $1.47 | $1.67 | +13.8% |
| 2024Q4 | $1.37 | $1.60 | +17.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*